A practical reference on counter-ion: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-10-29. Anything still debated is marked as such rather than presented as settled.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
==== Magnetic droplets in non-traditional systems ==== In traditional, droplet-based microfluidic systems, that is to say, a droplet in a channel which contains an immiscible oil that separates the droplets, movement of the droplets is achieved through differences in pressure or surface tension. In non-traditional, droplet-based microfluidic systems, such as those herein, other mechanisms of control are needed to manipulate the droplets. Application of a magnetic field to a microfluid array containing magnetic droplets allows for easily achieved sorting and arrangement of the droplets into useful patterns and configurations. These types of manipulations can be achieved via static or dynamic application of a magnetic field which allows for a high degree of control over magnetic droplets. Characterization of the degree of control over magnetic droplets includes measurements of the magnetic susceptibility of the ferrofluid, measurement of the change in droplet in substrate interface area in the presence of an applied magnetic field, and measurement of the "roll-off angle" or the angle at which the droplet would move in the presence of a magnetic field when the surface was tilted. Interactions between the water droplet and the surface can be manipulated by adjusting the structure of the microfluidic system itself by applying a magnetic field to iron-doped poly[dimethylsiloxane] (PDMS), a common material for microfluidic devices.
== Birman naming conventions == Many Birman breeders follow the French tradition of assigning all kittens born in a particular year given names that begin with the same letter of the alphabet. Countries with breeders using this convention include Australia, Canada, France, New Zealand, the U.K., and the U.S. Kittens born in 2016 would start with 'N', and in 2017 'O', and so on.
=== Building blocks for cell-adhesion === By looking at the genome of the Choanoflagellate, "Monosiga brevicollis", scientists have inferred that choanoflagellates play a key role in the development of multicellularity. Nicole King has done work looking at the genome of Monisiga brevicollis, and has found key protein domains that are shared between metazoans and choanoflagellates. These domains play a role in cell signalling and adhesion processes in metazoans. The finding that choanoflagellates also have these genes is an incredible discovery because it was previously thought that only metazoans had genes responsible for cell-cell communication and aggregation. This suggests that these domains play a key role in the origins of multicellularity since it ties a unicellular organism (choanoflagellates) to multicellular organisms (metazoans). It shows that the components required for multicellularity were present in the common ancestor between metazoans and choanoflagellates.
== Uses == One of the key uses for the compound is in production of the pesticide Malathion. It has also been used medically as a chemical depletory of glutathione. It has been studied extensively with regard to renal function. Other medical uses include treatment of breast cancer and its monitoring with Positron Emission Tomography. It is also used as a food additive and has Food and Drug Administration clearance for indirect food contact. In synthetic organic chemistry it is a dienophile and used in the Diels-Alder reaction. With the invention of polyaspartic technology the material also found another use. With this technology an amine is reacted with a dialkyl maleate - usually diethyl maleate - utilizing the Michael addition reaction. These products are then used in coatings, adhesives, sealants and elastomers.
==== Escherichia coli cells ==== Photo-methionine can be used to label recombinant proteins in Escherichia coli cells; though methionine in general is a rare amino acid so that means it could only give limited structural data. Nevertheless, photo-methionine was incorporated into Ca2+ regulating protein calmodulin (CaM that was 17-kDa) that has nine methionine's and studied via mass spectrometry (MS). What makes this method different is the use of mineral salts medium instead of DMEM (Dulbecco's Modified Eagle's Limiting Medium) or dialyzed fetal bovine serum for the incorporation into the cells. Using the mineral salt medium allowed the cells to be grown from the beginning in order to eliminate complicated steps with other protocols (incubating the cells in LB medium, followed by washing, and further incubating in the depleted medium), meaning that photo-methionine could be incorporated at the very beginning of the cell growth that had a high yield above 30%. Photo-methionine had shown no damage during the cell growth process and once photo-activated by UV-A light, CaM had nine distinct cross-link sites once MS had determined there was peaks of photo-methionine labeled CaM. Not only can photo-methionine be used for mapping 3D protein structure, studying protein-protein interactions, but now hydrophobic regions in the protein.
Sources: en.wikipedia.org
Valve was founded in Kirkland, Washington in 1996 by the former Microsoft employees Gabe Newell and Mike Harrington. For their first product, Valve settled on a concept for a horror first-person shooter (FPS) game. They did not want to build their own game engine, as this would have created too much work for a small team and Newell planned to innovate in different areas. Instead, Valve licensed the Quake engine and the Quake II engine from id Software and combined them with their own code. Newell estimated that around 75% of the final engine code was by Valve. As the project expanded, Valve cancelled development of a fantasy role-playing game, Prospero, and the Prospero team joined the Half-Life project. Half-Life was inspired by the FPS games Doom (1993) and Quake (1996), Stephen King's 1980 novella The Mist, and a 1963 episode of The Outer Limits titled "The Borderland". According to the designer Harry Teasley, Doom was a major influence and the team wanted Half-Life to "scare you like Doom did". The project had the working title Quiver, after the Arrowhead military base from The Mist. The name Half-Life was chosen because it was evocative of the theme, not clichéd, and had a corresponding visual symbol: the Greek letter λ (lower-case lambda), which represents the decay constant in the half-life equation. According to the designer Brett Johnson, the level design was inspired by environments in the manga series Akira.
The team is launched into space on modified ballistic missiles and approaches the alien ship by stealth. Four of the avout destroy the ship's main weapon before dying in combat. The rest of the team boards the ship and temporarily pass out from breathing alien air. The narrative now parallelizes across multiple timelines. In one narrative, Fraa Jad awakens Erasmas and leads him through the ship toward the command center. Upon being discovered and attacked by alien soldiers, Fraa Jad detonates the neutron bombs. In another narrative, soldiers take Erasmas and Fraa Jad captive and bring them to parley with the leader of the peaceful faction. In the final narrative, Erasmas awakens in a hospital on the starship and learns that diplomatic negotiations are underway thanks to the successful destruction of the alien weapon. Erasmas is told that Fraa Jad died in an accident during the launch, contradicting the other narratives. It remains ambiguous which (or how many) of these contradictory narratives are real, or how the narratives have influenced each other. It is implied that some Millenarian avout are capable of operating simultaneously in multiple parallel timelines, and that the Millenarians had called the alien ship to Arbre to disrupt the subjugation of the Avout by the Sæcular Power. Erasmas attends a diplomatic summit where a funeral ceremony is held for those lost on both sides and a peace process begins between the aliens and the Arbrans. On Arbre itself, the Sæcular Power and the avout have agreed to cooperate as equal powers.
The southern African territory of Rhodesia, officially Southern Rhodesia, was a unique case in the British Empire and Commonwealth: although a colony in name, it was internally self-governing and constitutionally not unlike a dominion. This situation dated back to 1923, when it was granted responsible government within the empire as a self-governing colony, following three decades of administration and development by the British South Africa Company. Britain had intended Southern Rhodesia's integration into the Union of South Africa as a new province, but this having been rejected by registered voters in the 1922 government referendum, the territory was moulded into a prospective dominion instead. It was empowered to run its own affairs in almost all respects, including defence. Whitehall's powers over Southern Rhodesia under the 1923 constitution were, on paper, considerable; the British Crown was theoretically able to cancel any passed bill within a year, or alter the constitution however it wished. These reserved powers were intended to protect the indigenous black Africans from discriminatory legislation and to safeguard British commercial interests in the colony, but as Claire Palley comments in her constitutional history of the country, it would have been extremely difficult for Whitehall to enforce such actions, and attempting to do so would have probably caused a crisis. In the event, they were never exercised. A generally co-operative relationship developed between Whitehall and the colonial government and civil service in Salisbury, and dispute was rare.
== Location and classification == BAT's presence in adult humans was discovered in 2003 during FDG-PET scans to detect metastatic cancers. Using these scans and data from human autopsies, several deposits have been identified. In infants, brown adipose tissue deposits include: interscapular, supraclavicular, suprarenal, pericardial, para-aortic and around the pancreas, kidney and trachea. These deposits gradually get more white fat-like during adulthood. In adults, the deposits that are most often detected in FDG-PET scans are the supraclavicular, paravertebral, mediastinal, para-aortic and suprarenal ones. It remains to be determined whether these deposits are 'classical' brown adipose tissue or beige/brite fat.
Human Nutrition Unit; School of Molecular Bioscience. "Glycemic Index". International GI database. University of Sydney. – Searchable database of over 2600 foods with their glycemic index and load values. List of low GI foods Glycemic Index and Glycemic Load calculator Total values for any combinations of foods and any number of servings are computed according to FAO/WHO specifications). Diabetes UK: Glycaemic Index and Diabetes
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
Bacteriostatic water or sterile saline is commonly used to dissolve the powder. The choice of solvent affects stability and preservation. Aqueous solutions are kept refrigerated and are not intended for long-term storage.